PPLPHARMA

reported a net loss of Rs 136.19 crore for the December quarter due to inventory destocking, weak CDMO orders, and regulatory delays. Revenue declined 3% YoY to Rs 2,140 crore and EBITDA contracted 32% to Rs 239 crore. The consumer healthcare division delivered strong momentum, with power brands growing 30% YoY.